Description Overview Tirzepatide is a dual GIP and GLP-1 receptor agonist that improves insulin sensitivity and weight loss, combined with Methylcobalamin for additional metabolic benefits
According to recent studies Tirzep is effective in weight management for both diabetic & non-diabetic obese patients & capable to reduce 16% weight in 72 weeks with upto 22%.ACI is proud to offer this accessible solution for managing Diabesity in our nation
Impact on Daily Life While diarrhea can be inconvenient, most patients find it does not significantly impact their daily activities
really helps with focus at work
Higher doses produce more pronounced gastric emptying delays, which produce more fermentation, which produces more gas, which produces more burping
Berberine GI side effects in clinical trials affect 10 to 35% of users, with diarrhea reported specifically in 15 to 25% of those taking 1000 to 1500mg daily